NL8602933A - Geneesmiddel voor het behandelen van dementie. - Google Patents

Geneesmiddel voor het behandelen van dementie. Download PDF

Info

Publication number
NL8602933A
NL8602933A NL8602933A NL8602933A NL8602933A NL 8602933 A NL8602933 A NL 8602933A NL 8602933 A NL8602933 A NL 8602933A NL 8602933 A NL8602933 A NL 8602933A NL 8602933 A NL8602933 A NL 8602933A
Authority
NL
Netherlands
Prior art keywords
dementia
medicament according
medicament
acyloxyalkanoylcholine
acid residue
Prior art date
Application number
NL8602933A
Other languages
English (en)
Dutch (nl)
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NL8602933A publication Critical patent/NL8602933A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8602933A 1985-11-19 1986-11-19 Geneesmiddel voor het behandelen van dementie. NL8602933A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25788185 1985-11-19
JP60257881A JPH0733332B2 (ja) 1985-11-19 1985-11-19 痴呆症状改善・治療剤

Publications (1)

Publication Number Publication Date
NL8602933A true NL8602933A (nl) 1987-06-16

Family

ID=17312478

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8602933A NL8602933A (nl) 1985-11-19 1986-11-19 Geneesmiddel voor het behandelen van dementie.

Country Status (12)

Country Link
US (1) US4713376A (de)
JP (1) JPH0733332B2 (de)
AU (1) AU590640B2 (de)
CA (1) CA1278519C (de)
CH (1) CH668184A5 (de)
DE (1) DE3639378A1 (de)
DK (1) DK169607B1 (de)
FR (1) FR2590170B1 (de)
GB (1) GB2184653B (de)
IT (1) IT1200041B (de)
NL (1) NL8602933A (de)
SE (1) SE469059B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
ES2162520T3 (es) * 1998-02-13 2001-12-16 Schwabe Willmar Gmbh & Co Medicamentos basados en hiperforina y/o extractos de hiperforina.
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
WO2005019157A1 (en) * 2003-08-15 2005-03-03 Patel Hasmukh B Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
US7803842B2 (en) * 2004-06-08 2010-09-28 Hass Patel Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
WO2006059252A2 (en) * 2004-11-12 2006-06-08 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
JP2008520647A (ja) * 2004-11-16 2008-06-19 ニューロケム （インターナショナル） リミテッド Ｃｎｓおよびアミロイド関連疾患治療のための化合物
CA2900876A1 (en) 2004-12-22 2006-08-17 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
AU2006342958A1 (en) * 2005-12-22 2007-11-08 Bellus Health (International) Limited Treatment of renal disorders, diabetic nephropathy and dyslipidemias
WO2009019534A2 (en) 2006-10-12 2009-02-12 Bellus Health (International) Limited Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
EP2120905A1 (de) * 2006-12-22 2009-11-25 BELLUS Health (International) Limited Verfahren, verbindungen und zusammensetzungen zur behandlung von stoffwechselerkrankungen und diabetes
NZ578475A (en) * 2007-02-07 2011-05-27 Pulmagen Therapeutics Synergy Napadisylate salt of a muscarinic m3 antagonist
TW201115409A (en) * 2009-10-29 2011-05-01 Hannspree Inc A mouse capable of generating vapor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336350A (en) * 1970-12-28 1973-11-07 Toyama Chemical Co Ltd Choline derivatives and process for producing the same
DE2425983C3 (de) * 1973-06-12 1978-09-14 Toyama Chemical Co. Ltd., Tokio Sulfonsäuresalze von Acylcholinen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzung
JPS5221490A (en) * 1975-08-12 1977-02-18 Mitsubishi Rayon Co Printing method
JPS592904B2 (ja) * 1976-09-18 1984-01-21 日本ビクター株式会社 デイスプレイ装置
JPS551251A (en) * 1978-06-20 1980-01-08 Yamaha Motor Co Ltd Brake pedal for motorcycle
JPS58180463A (ja) * 1982-04-19 1983-10-21 Toyama Chem Co Ltd ビスコリンジスルホナ−ト類の製造法

Also Published As

Publication number Publication date
GB2184653A (en) 1987-07-01
DE3639378C2 (de) 1990-05-10
IT1200041B (it) 1989-01-05
SE8604950D0 (sv) 1986-11-19
GB2184653B (en) 1989-11-15
DK550586A (da) 1987-05-20
SE469059B (sv) 1993-05-10
DK550586D0 (da) 1986-11-18
GB8627484D0 (en) 1986-12-17
AU590640B2 (en) 1989-11-09
JPH0733332B2 (ja) 1995-04-12
JPS62120317A (ja) 1987-06-01
US4713376A (en) 1987-12-15
SE8604950L (sv) 1987-05-20
AU6530286A (en) 1987-05-21
DE3639378A1 (de) 1987-05-27
DK169607B1 (da) 1994-12-27
CH668184A5 (de) 1988-12-15
CA1278519C (en) 1991-01-02
FR2590170A1 (fr) 1987-05-22
FR2590170B1 (fr) 1990-08-24
IT8648670A0 (it) 1986-11-19

Similar Documents

Publication Publication Date Title
NL8602933A (nl) Geneesmiddel voor het behandelen van dementie.
KR0150631B1 (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
US4636494A (en) Process and composition for treating disorders by administering amphetamine and choline
HU217132B (hu) Riluzol alkalmazása AIDS-szel kapcsolatos idegi rendellenességek kezelésére alkalmas gyógyszerkészítmények előállítására
EP0026223A1 (de) Verfahren und zusammensetzung zum behandeln von störungen durch verabreichung von lezithin
JP2022523402A (ja) 術後認知機能障害の予防及び治療のための化合物
EP0437128B1 (de) Verwendung von Fluorochinolon-Derivaten zur Behandlung der Pneumocystis carinii Pneumonie
US4346084A (en) Process and composition for treating disorders by administering lithium and choline
FR2511598A1 (fr) Produit pharmaceutique contenant une substance activant la circulation sanguine, en combinaison avec un concentrat de dialyse de sang de veau deproteine
WO2017057562A1 (ja) 末梢神経障害又は脊髄損傷の治療剤及び／又は予防剤
RU2341261C2 (ru) Композиции, содержащие эпотилоны, и их применение для лечения карциноидного синдрома
KR20050119104A (ko) 치환된 퀴놀린과 치환된 디페닐설폰을 함유하는 조성물과방법
KR0133555B1 (ko) 5-플루오로우라실계 화합물에 기인한 염증의 발생을 억제할 수 있는 비-주사제 형태의 항암조성물
JPS6124377B2 (de)
EP1084704B1 (de) Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie
DE69200365T2 (de) Pharmazeutische Zusammensetzung zur Verbesserung von Dysuria.
WO2007113170A1 (de) Verwendung von strobilurinen zur behandlung von störungen des eisen-stoffwechsels
CA2064999A1 (fr) Derives de la 5-amino-1,2,3,4 tetrahydro-acridine et utilisation comme medicaments
DE69016866T2 (de) Verwendung von Bis(4-hydroxyphenylthio)methan-Derivaten zur Behandlung von Diabetes mellitus.
EP0271023A2 (de) Verwendung von Dihydrophenylaminosäurederivaten und diese enthaltende Arzneimittel zur Immunmodulation und Cytostase
US20040014681A1 (en) Method for treating dermatoses and tissue damage
RU2601622C1 (ru) Средство, обладающее эндотелиопротекторным действием в условиях экспериментального сахарного диабета и нарушения мозгового кровообращения
KR0168649B1 (ko) 비스(3,5-디-알킬-4-히드록시페닐티오)메탄을 유효 성분으로 함유하는 고트리글리세리드혈증 치료용 제약 조성물
KR20050108402A (ko) 만성 피부 질환의 치료제 및/또는 예방제
RU2061481C1 (ru) Средство, обладающее антиагрегационной активностью

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable